RESISTANCE CHARACTERISTICS OF BLOOD CULTURE ISOLATES OF ENTEROBACTER-CLOACAE WITH SPECIAL REFERENCE TO BETA-LACTAMASES AND RELATION TO PRECEDING ANTIMICROBIAL THERAPY

被引:5
作者
WEISCHER, M
SCHUMACHER, H
KOLMOS, HJ
机构
[1] STATENS SERUM INST,DEPT HOSP INFECT & ANTIBIOT,DK-2300 COPENHAGEN,DENMARK
[2] HVIDOVRE UNIV HOSP,DEPT CLIN MICROBIOL,DK-2650 HVIDOVRE,DENMARK
关键词
ENTEROBACTER-ELOACAE; SUSCEPTIBILITY PATTERNS; RESISTANT MUTANTS; BETA-LACTAMASES; PRECEDING ANTIMICROBIAL THERAPY;
D O I
10.1111/j.1699-0463.1994.tb04884.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Resistance characteristics of 53 blood culture isolates of E cloacae were examined and correlated with antimicrobial treatment preceding bacteraemia. Resistance patterns of 22 antimicrobial agents, presence of resistant mutants, and inducibility of beta-lactamase were investigated; furthermore, population analysis and investigation of beta-lactamase production of selected isolates were performed. Thirty-two isolates (60%) were resistant to cephalothin and/or cefoxitin and/or ampicillin, and 14 isolates (26%) had further resistance characteristics, 7 of the 14 being resistant to non-beta-lactam antibiotics. All ampicillin-susceptible and 76% of cefotaxime-susceptible isolates had resistant mutants in the zone of inhibition when high inoculum was used. All isolates investigated had inducible chromosomal beta-lactamases, and, in addition, two isolates had an enzyme corresponding with TEM-1. Correlation of resistance patterns and antimicrobial treatment preceding bacteraemia showed that treatment with a third-generation cephalosporin was associated with beta-lactam multiresistance. In conclusion, susceptibility testing of beta-lactam antibiotics of Enterobacter must be interpreted with caution and monotherapy with an extended-spectrum cephalosporin should be avoided unless presence of resistant mutants and inducibility of beta-lactamase can be excluded.
引用
收藏
页码:356 / 366
页数:11
相关论文
共 41 条
[1]  
BODEY GP, 1991, REV INFECT DIS, V13, P550
[2]  
Casals JB, 1991, ANTIBACTERIAL ANTIFU
[3]   ENTEROBACTER BACTEREMIA - CLINICAL-FEATURES AND EMERGENCE OF ANTIBIOTIC-RESISTANCE DURING THERAPY [J].
CHOW, JW ;
FINE, MJ ;
SHLAES, DM ;
QUINN, JP ;
HOOPER, DC ;
JOHNSON, MP ;
RAMPHAL, R ;
WAGENER, MM ;
MIYASHIRO, DK ;
YU, VL .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) :585-590
[4]  
CULLMANN W, 1984, J GEN MICROBIOL, V130, P1781
[5]   EMERGENCE OF RESISTANCE IN GRAM-NEGATIVE BACTERIA DURING THERAPY WITH EXPANDED-SPECTRUM CEPHALOSPORINS [J].
DWORZACK, DL ;
PUGSLEY, MP ;
SANDERS, CC ;
HOROWITZ, EA .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (04) :456-459
[6]   PATIENTS ENDOGENOUS FLORA AS THE SOURCE OF NOSOCOMIAL ENTEROBACTER IN CARDIAC-SURGERY [J].
FLYNN, DM ;
WEINSTEIN, RA ;
NATHAN, C ;
GASTON, MA ;
KABINS, SA .
JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (02) :363-368
[7]   CLINICAL CONSEQUENCES OF DEVELOPMENT OF RESISTANCE TO 3RD GENERATION CEPHALOSPORINS [J].
FOLLATH, F ;
COSTA, E ;
THOMMEN, A ;
FREI, R ;
BURDESKA, A ;
MEYER, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (04) :446-450
[8]  
GALLAGHER PG, 1990, REV INFECT DIS, V12, P808
[9]   SEROTYPES AND BIOCHEMICAL PROFILES OF BRITISH HOSPITAL STRAINS OF ENTEROBACTER-CLOACAE IN RELATION TO SITE OF INFECTION AND ANTIBIOTIC SUSCEPTIBILITY [J].
GASTON, MA ;
CREESMORRIS, JA ;
PITT, TL .
JOURNAL OF HOSPITAL INFECTION, 1987, 10 (01) :17-27
[10]   RESISTANCE TO CEFAMANDOLE - DEREPRESSION OF BETA-LACTAMASES BY CEFOXITIN AND MUTATION IN ENTEROBACTER-CLOACAE [J].
GOOTZ, TD ;
SANDERS, CC ;
GOERING, RV .
JOURNAL OF INFECTIOUS DISEASES, 1982, 146 (01) :34-42